COMMUNIQUÉS West-GlobeNewswire

CASMED Reports Third-Quarter 2018 Financial Results

31/10/2018 - 13:00

FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS [...]

Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018

31/10/2018 - 13:00

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]

Sun BioPharma, Inc. Announces Leadership Changes

31/10/2018 - 13:00

David B. Kaysen Steps Down as President, CEO and Board Member Effective October 31, 2018 Michael T. Cullen MD, MBA, Executive Chairman, Elected President and CEO by Board of Directors Effective October 31, 2018 [...]

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

31/10/2018 - 13:00

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the [...]

HempAmericana Readies to Launch its Own Proprietary CBD Oil

31/10/2018 - 13:00

NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company is about to take delivery of the final two pieces [...]

Anchiano Therapeutics Announces Confidential Submission of Draft Registration Statement for U.S. Initial Public Offering

31/10/2018 - 13:00

CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]

Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast

31/10/2018 - 13:00

CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that it will release its financial results for the third quarter ended September 30, 2018 and provide a [...]

Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany

31/10/2018 - 08:31

Interim report for Enzymatica AB (publ) JANUARY-SEPTEMBER 2018 Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany Q3 Net sales reached SEK 13.2 (24.8) million. Net profit after tax [...]

Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment

31/10/2018 - 08:00

Enrollment complete ahead of schedule Top line data expected in January 2019 LONDON, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical [...]

Motif Bio to participate at upcoming Jefferies London Healthcare Conference

31/10/2018 - 08:00

NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will participate in [...]

Sanofi Q3 2018 Performance Confirms Return to Growth

31/10/2018 - 07:32

Paris, October 31, 2018 Sanofi Q3 2018 Performance Confirms Return to Growth Q3 2018 Change Change at CER 9M 2018 Change Change at CER IFRS net sales reported €9,392m +3.7% +6.3% €25,466m -3.5% +2.1% IFRS net income [...]

La performance de Sanofi au T3 2018 confirme son retour à la croissance

31/10/2018 - 07:32

Paris, le 31 octobre 2018 La performance de Sanofi au T3 2018 confirme son retour à la croissance T3 2018 Variation Variation à TCC 9M 2018 Variation Variation à TCC Chiffre d'affaires net IFRS publié €9 392m +3,7% +6,3 [...]

ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018

31/10/2018 - 07:30

Geneva, Switzerland and Boston, MA –October 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]

Medical patients’ access to Hydropothecary cannabis products remains a priority for HEXO Corp

30/10/2018 - 23:41

GATINEAU, Quebec, Oct. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp has wasted no time in reassuring its current medical patients that it has safeguarded products and bandwidth to continue to deliver the quality, award- [...]

Accès des patients aux produits de cannabis Hydropothecary : toujours une priorité pour HEXO Corp

30/10/2018 - 23:41

GATINEAU, Québec,, 30 oct. 2018 (GLOBE NEWSWIRE) -- HEXO Corp s’empresse de rassurer les patients qui font actuellement partie de sa clientèle médicale : suffisamment de stocks de toute sa gamme ont été mis de côté pour [...]

ProQR obtient de Ionis Pharmaceuticals des droits mondiaux sous licence sur un médicament candidat en ophtalmologie

30/10/2018 - 23:15

ProQR reçoit une licence mondiale exclusive pour IONIS-RHO-2.5 Rx , désormais dénommé QR-1123, destiné au traitement de la rétinite pigmentaire autosomique dominante (adRP), une forme rare de cécité héréditaire sans [...]

Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia Therapeutics

30/10/2018 - 22:31

Keryx Board Unanimously Supports Merger with Akebia and Encourages Stockholders to vote “ FOR ” the Merger Proposals Keryx Special Meeting of Stockholders Scheduled for December 11, 2018 BOSTON, Oct. 30, 2018 (GLOBE [...]

UPDATE - Cutera to Present at Three Upcoming Healthcare Conferences

30/10/2018 - 22:23

BRISBANE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]

Helix BioPharma Corp. Closes Private Placement

30/10/2018 - 22:05

RICHMOND HILL, Ontario, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]